The burden of inflammatory bowel disease in Europe

Johan Burisch, Tine Jess, Matteo Martinato, Peter L. Lakatos

Research output: Contribution to journalReview article

436 Citations (Scopus)


Inflammatory bowel diseases (IBD) are chronic disabling gastrointestinal disorders impacting every aspect of the affected individual's life and account for substantial costs to the health care system and society. New epidemiological data suggest that the incidence and prevalence of the diseases are increasing and medical therapy and disease management have changed significantly in the last decade. An estimated 2.5-3. million people in Europe are affected by IBD, with a direct healthcare cost of 4.6-5.6. bn Euros/year. Therefore, the aim of this review is to describe the burden of IBD in Europe by discussing the latest epidemiological data, the disease course and risk for surgery and hospitalization, mortality and cancer risks, as well as the economic aspects, patients' disability and work impairment.

Original languageEnglish
Pages (from-to)322-337
Number of pages16
JournalJournal of Crohn's and Colitis
Issue number4
Publication statusPublished - May 1 2013


  • Disability
  • Economy
  • Incidence
  • Inflammatory bowel disease
  • Mortality
  • Surgery

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'The burden of inflammatory bowel disease in Europe'. Together they form a unique fingerprint.

  • Cite this